| Year |
Citation |
Score |
| 2021 |
Amminger GP, Lin A, Kerr M, Weller A, Spark J, Pugh C, O'Callaghan S, Berger M, Clark SR, Scott JG, Baker A, McGregor I, Cotter D, Sarnyai Z, Thompson A, et al. Cannabidiol for at risk for psychosis youth: A randomized controlled trial. Early Intervention in Psychiatry. PMID 34190422 DOI: 10.1111/eip.13182 |
0.577 |
|
| 2020 |
McLaverty A, Allott KA, Berger M, Hester R, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, et al. Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis. Early Intervention in Psychiatry. PMID 32893462 DOI: 10.1111/Eip.13025 |
0.34 |
|
| 2020 |
Berger M, Amminger GP, McDermott R, Guest PC, Sarnyai Z. Testing the Effects of Dietary Seafood Consumption on Depressive Symptoms. Methods in Molecular Biology (Clifton, N.J.). 2138: 233-242. PMID 32219752 DOI: 10.1007/978-1-0716-0471-7_15 |
0.57 |
|
| 2020 |
Ketheesan S, Rinaudo M, Berger M, Wenitong M, Juster RP, McEwen BS, Sarnyai Z. Stress, Allostatic Load and Mental Health in Indigenous Australians. Stress (Amsterdam, Netherlands). 1-26. PMID 32070158 DOI: 10.1080/10253890.2020.1732346 |
0.645 |
|
| 2020 |
Berger M, Burkhardt E, Yung A, Nelson B, Francey S, Lin A, Wood S, Thompson A, Berger G, Philipps L, Harrington S, McGorry P, Yolken R, Amminger GP. M22. IGG ANTIBODIES TO TOXOPLASMA GONDII ARE ASSOCIATED WITH INCREASED LONG-TERM RISK FOR PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 46: S141-S142. DOI: 10.1093/Schbul/Sbaa030.334 |
0.367 |
|
| 2020 |
Schlögelhofer M, McGorry PD, Nelson B, Berger M, Markulev C, Pan Yuen H, Schäfer MR, Mossaheb N, Smesny S, Hickie IB, Berger G, Chen EYH, De Haan L, Nieman D, Nordentoft M, et al. T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL Schizophrenia Bulletin. 46: S244-S245. DOI: 10.1093/Schbul/Sbaa029.594 |
0.356 |
|
| 2019 |
Hartmann JA, Schmidt SJ, McGorry PD, Berger M, Berger GE, Chen EYH, de Haan L, Hickie IB, Lavoie S, Markulev C, Mossaheb N, Nieman DH, Nordentoft M, Polari A, Riecher-Rössler A, et al. Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial. Behaviour Research and Therapy. 124: 103527. PMID 31790853 DOI: 10.1016/J.Brat.2019.103527 |
0.358 |
|
| 2019 |
Amminger GP, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, et al. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis. Biological Psychiatry. PMID 31690495 DOI: 10.1016/J.Biopsych.2019.08.030 |
0.321 |
|
| 2019 |
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, et al. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis. Schizophrenia Research. PMID 31606244 DOI: 10.1016/J.Schres.2019.08.033 |
0.329 |
|
| 2019 |
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, et al. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people. Schizophrenia Research. PMID 31301881 DOI: 10.1016/J.Schres.2019.06.020 |
0.326 |
|
| 2019 |
Berger M, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, et al. Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial. Frontiers in Psychiatry. 10: 393. PMID 31244693 DOI: 10.3389/Fpsyt.2019.00393 |
0.348 |
|
| 2019 |
Lavoie S, Allott K, Amminger P, Bartholomeusz C, Berger M, Breakspear M, Henders AK, Lee R, Lin A, McGorry P, Rice S, Schmaal L, Wood SJ. Harmonised collection of data in youth mental health: Towards large datasets. The Australian and New Zealand Journal of Psychiatry. 4867419844322. PMID 30995080 DOI: 10.1177/0004867419844322 |
0.308 |
|
| 2019 |
Berger M, Taylor S, Harriss L, Campbell S, Thompson F, Jones S, Sushames A, Amminger GP, Sarnyai Z, McDermott R. Hair cortisol, allostatic load, and depressive symptoms in Australian Aboriginal and Torres Strait Islander people. Stress (Amsterdam, Netherlands). 1-9. PMID 30835590 DOI: 10.1080/10253890.2019.1572745 |
0.636 |
|
| 2018 |
Berger M, Lavoie S, McGorry PD, Nelson B, Markulev C, Yuen HP, Schaefer M, Sarnyai Z, Amminger GP. Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study. Schizophrenia Research. PMID 30340917 DOI: 10.1016/J.Schres.2018.10.002 |
0.638 |
|
| 2018 |
Harriss LR, Kyle M, Connolly K, Murgha E, Bulmer M, Miller D, Munn P, Neal P, Pearson K, Walsh M, Campbell S, Berger M, McDermott R, McDonald M. Screening for depression in young Indigenous people: building on a unique community initiative. Australian Journal of Primary Health. PMID 30089528 DOI: 10.1071/Py18006 |
0.344 |
|
| 2018 |
Berger M, Taylor S, Harriss L, Campbell S, Thompson F, Jones S, Makrides M, Gibson R, Paul Amminger G, Sarnyai Z, McDermott R. Cross-sectional association of seafood consumption, polyunsaturated fatty acids and depressive symptoms in two Torres Strait communities. Nutritional Neuroscience. 1-10. PMID 30073906 DOI: 10.1080/1028415X.2018.1504429 |
0.588 |
|
| 2018 |
Berger M, Juster RP, Westphal S, Amminger GP, Bogerts B, Schiltz K, Bahn S, Steiner J, Sarnyai Z. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis. Psychoneuroendocrinology. 90: 35-42. PMID 29427955 DOI: 10.1016/J.Psyneuen.2018.02.001 |
0.654 |
|
| 2018 |
Berger M, Lavoie S, McGorry PD, Nelson B, Markulev C, Yuen HP, Schaefer M, Sarnyai Z, Amminger GP. S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 44: S326-S327. DOI: 10.1093/Schbul/Sby018.795 |
0.634 |
|
| 2018 |
Berger M, McGorry PD, Nelson B, Markulev C, Yuen HP, Schaefer M, Mossaheb N, Schlogelhofer M, Smesny S, Hickie I, Berger G, Chen E, De Haan L, Nieman D, Nordentoft M, et al. T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY Schizophrenia Bulletin. 44: S116-S116. DOI: 10.1093/Schbul/Sby016.285 |
0.316 |
|
| 2017 |
Berger ME, Smesny S, Kim SW, Davey CG, Rice S, Sarnyai Z, Schlögelhofer M, Schäfer MR, Berk M, McGorry PD, Amminger GP. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study. Translational Psychiatry. 7: e1220. PMID 28850110 DOI: 10.1038/Tp.2017.190 |
0.589 |
|
| 2017 |
Mossaheb N, Schäfer MR, Schlögelhofer M, Klier CM, Smesny S, McGorry PD, Berger M, Amminger GP. Predictors of longer-term outcome in the Vienna omega-3 high-risk study. Schizophrenia Research. PMID 28823721 DOI: 10.1016/J.Schres.2017.08.010 |
0.353 |
|
| 2017 |
Steiner J, Berger M, Guest PC, Dobrowolny H, Westphal S, Schiltz K, Sarnyai Z. Assessment of Insulin Resistance Among Drug-Naive Patients With First-Episode Schizophrenia in the Context of Hormonal Stress Axis Activation. Jama Psychiatry. PMID 28724123 DOI: 10.1001/Jamapsychiatry.2017.1983 |
0.61 |
|
| 2017 |
Langbein K, Schmidt U, Schack S, Biesel NJ, Rudzok M, Amminger GP, Berger M, Sauer H, Smesny S. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study. Schizophrenia Research. PMID 28602647 DOI: 10.1016/J.Schres.2017.06.007 |
0.407 |
|
| 2017 |
Amminger GP, Berger M, Rice SM, Davey CG, Schäfer MR, McGorry PD. Novel biotherapies are needed in youth mental health. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. 25: 117-120. PMID 28375061 DOI: 10.1177/1039856217698237 |
0.376 |
|
| 2017 |
Lavoie S, Berger M, Schlögelhofer M, Schäfer MR, Rice S, Kim SW, Hesse J, McGorry PD, Smesny S, Amminger GP. Erythrocyte glutathione levels as long-term predictor of transition to psychosis. Translational Psychiatry. 7: e1064. PMID 28323286 DOI: 10.1038/Tp.2017.30 |
0.389 |
|
| 2017 |
Berger M, Leicht A, Slatcher A, Kraeuter AK, Ketheesan S, Larkins S, Sarnyai Z. Cortisol Awakening Response and Acute Stress Reactivity in First Nations People. Scientific Reports. 7: 41760. PMID 28139727 DOI: 10.1038/Srep41760 |
0.744 |
|
| 2017 |
Smesny S, Milleit B, Schaefer MR, Hesse J, Schlögelhofer M, Langbein K, Hipler UC, Berger M, Cotter DR, Sauer H, McGorry PD, Amminger GP. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study. Schizophrenia Research. PMID 28126360 DOI: 10.1016/J.Schres.2017.01.026 |
0.371 |
|
| 2017 |
Berger M, Juster R, Westphal S, Amminger GP, Steiner J, Sarnyai Z. 8. Allostatic Load is Associated With Positive Symptoms in Schizophrenia and First-Episode Psychosis and Decreases With Antipsychotic Therapy Schizophrenia Bulletin. 43: S9-S10. DOI: 10.1093/Schbul/Sbx021.027 |
0.647 |
|
| 2016 |
Berger M, Kraeuter AK, Romanik D, Malouf P, Amminger GP, Sarnyai Z. Cortisol Awakening Response in Patients with Psychosis: Systematic Review and Meta-Analysis. Neuroscience and Biobehavioral Reviews. PMID 27229759 DOI: 10.1016/J.Neubiorev.2016.05.027 |
0.754 |
|
| 2016 |
Berger M, Kraeuter A, Romanik D, Malouf P, Amminger G, Sarnyai Z. Cortisol awakening response in patients with schizophrenia, first-episode psychosis and at-risk mental states: a meta-analysis European Neuropsychopharmacology. 26: S487-S488. DOI: 10.1016/S0924-977X(16)31497-3 |
0.746 |
|
| 2016 |
Berger M, Leicht A, Slatcher A, Kraeuter A, Ketheesan S, Larkins S, Elston J, Sarnyai Z. Flattened cortisol awakening response and altered stress reactivity as potential mediators of ethnic minority associated risk in first nations people European Neuropsychopharmacology. 26: S198. DOI: 10.1016/S0924-977X(16)31039-2 |
0.744 |
|
| 2015 |
Sarnyai Z, Berger M, Jawan I. Allostatic load mediates the impact of stress and trauma on physical and mental health in Indigenous Australians. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. PMID 26646603 DOI: 10.1177/1039856215620025 |
0.629 |
|
| 2015 |
Berger M, Juster RP, Sarnyai Z. Mental health consequences of stress and trauma: allostatic load markers for practice and policy with a focus on Indigenous health. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. PMID 26432654 DOI: 10.1177/1039856215608281 |
0.611 |
|
| 2015 |
Berger M, Sarnyai Z. "More than skin deep": stress neurobiology and mental health consequences of racial discrimination. Stress (Amsterdam, Netherlands). 18: 1-10. PMID 25407297 DOI: 10.3109/10253890.2014.989204 |
0.605 |
|
| 2014 |
Berger M, Piralic-Spitzl S, Aigner M. Trauma and posttraumatic stress disorder in transcultural patients with chronic pain. Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft ã–Sterreichischer Nervenã¤Rzte Und Psychiater. 28: 185-91. PMID 25274146 DOI: 10.1007/S40211-014-0122-X |
0.316 |
|
| Show low-probability matches. |